Allogene Therapeutics Inc (ALLO)
Cost of Revenue
$0.00
TTM · Period ending: · USD
ALLO Cost of Revenue
Latest reported$0.00period ending
Latest reported$0.00period ending
ALLO Cost of Revenue ($0.00 → $0.00)
Annual cost of revenue
High-resolution chart · PNG
ALLO cost of revenue history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 12,359,000 | |
| 0 | |
| 0 | |
| 14,295,000 | |
| 0 | |
| 11,541,000 | |
| 5,027,000 | |
| 0 | |
| 0 |